Free Trial
OTCMKTS:NVZMY

Novozymes A/S (NVZMY) Stock Price, News & Analysis

Novozymes A/S logo
$61.67 -0.68 (-1.08%)
As of 09/19/2025 03:59 PM Eastern

About Novozymes A/S Stock (OTCMKTS:NVZMY)

Advanced

Key Stats

Today's Range
$61.60
$62.46
50-Day Range
$60.50
$71.01
52-Week Range
$53.95
$75.99
Volume
43,711 shs
Average Volume
42,197 shs
Market Capitalization
$28.88 billion
P/E Ratio
39.03
Dividend Yield
0.60%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVZMY Stock News Headlines

REVEALED: Something Big Happening Behind White House Doors
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
Novozymes A/S (NSIS-B.CO) - Yahoo Finance
NVZMY Novozymes A/S - Seeking Alpha
See More Headlines

NVZMY Stock Analysis - Frequently Asked Questions

Novozymes A/S's stock was trading at $56.5399 at the beginning of 2025. Since then, NVZMY stock has increased by 9.1% and is now trading at $61.67.

Novozymes A/S (OTCMKTS:NVZMY) released its quarterly earnings data on Wednesday, January, 31st. The biotechnology company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.47 by $0.11. The biotechnology company earned $664.46 million during the quarter.

The following companies are subsidiaries of Novozymes A/S: PrecisionBiotics Group Limited, OrganoBalance GmbH, Pacific Vet Group-USA, Allopartis, TJ Technologies, Iogen Bio-Products, Natural Industries, and more.

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
1/31/2024
Ex-Dividend for 9/11 Dividend
9/02/2025
Record date for 9/11 Dividend
9/03/2025
Dividend Payable
9/11/2025
Today
9/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
CHEM - SPECIALTY
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMY
Previous Symbol
OTC:NVZMY
CIK
1131345
Employees
10,582
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
39.03
Forward P/E Ratio
33.88
P/E Growth
1.21
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
1.75
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$4.15 billion
Price / Sales
6.96
Cash Flow
$1.86 per share
Price / Cash Flow
33.21
Book Value
$25.82 per share
Price / Book
2.39

Miscellaneous

Outstanding Shares
468,300,000
Free Float
N/A
Market Cap
$28.88 billion
Optionable
Not Optionable
Beta
0.93

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:NVZMY) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners